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Antimicrobial prophylaxis to prevent surgical site infection in Adolescent 
Idiopathic scoliosis patients undergoing posterior spinal fusion– 2 doses versus 
antibiotics till drain removal 
 
 1 
ABSTRACT 2 
Purpose: There is much variation in the choice, timing and duration of antimicrobial 3 
prophylaxis for preventing surgical site infections (SSI) but no guideline exists for scoliosis 4 
surgery. The aim of study was to compare the efficacy of two antimicrobial prophylaxis 5 
(AMP) protocols with cephazolin in preventing SSI in adolescent idiopathic scoliosis (AIS). 6 
Methods: A retrospective comparative analysis of two post-operative AMP protocols (two 7 
postoperative doses versus continued antibiotics till drain removal) was performed. Patient 8 
characteristics, pre-operative, intra- and post-operative risk factors for infection, drain use, 9 
generic drug name and number of doses administered were recorded from 226 patients with 10 
AIS who had undergone posterior spinal fusion. Details of superficial or deep SSI and wound 11 
healing aberrations, and serious adverse events were recorded. Analysis was performed to 12 
evaluate differences in the pre-, intra- and post-operative variables between the two groups. 13 
Results: 155 patients received 2 postoperative doses of AMP and 71 patients had antibiotics 14 
till drain removal. The average follow-up was 43 months. The overall rate of SSI was 1.7% 15 
for the spine wound and 1.3% for the iliac crest wound. 1.9% of patients with 2 doses of 16 
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AMP and 1.4% of patients with antibiotics till drain removal had SSI. No adverse reactions 1 
attributable to cephazolin were observed. 2 
Conclusions: This is the first study on the AMP protocol in scoliosis surgery for SSI 3 
prevention. Results suggest that two doses of AMP are as effective as continued antimicrobial 4 
use until drain removal. Cephazolin appears to be effective and safe for prophylaxis. 5 
 6 
Key Words: Antimicrobial prophylaxis; adolescent idiopathic scoliosis; posterior spinal 7 
fusion 8 
9 
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INTRODUCTION 1 
Surgical site infection (SSI) after spinal fusion results in increased patient morbidity, 2 
prolonged hospital stay, long-term administration of antimicrobial drugs, multiple surgeries, 3 
hardware removal, pseudarthrosis and added health-care cost.[1-5] The prevalence of post-4 
operative SSI increases with the complexity of the procedure and is reported to range from 5 
<1% for discectomy[6,7] to as high as 10% for instrumentation surgery.[8,9] In adolescent 6 
idiopathic scoliosis (AIS) surgery, the reported rate of infection is between 0.71% and 7 
6.9%.[10-15] 8 
Pre-operative antimicrobial prophylaxis (AMP) is one of the keys to reduce the rate of 9 
SSI.[6,16-18] There is however, a great deal of variation regarding the choice of prophylactic 10 
antibiotics, optimal timing and duration of treatment.[19,20] Surgical AMP refers to a very 11 
brief course of antimicrobials initiated just before surgery.[21-24] It is a critically timed 12 
adjunct used to reduce the microbial burden of the intra-operative wound to a level that 13 
cannot overwhelm host defences, but not to sterilize tissues. The initial dose of antimicrobial 14 
is timed so that bactericidal concentration is established in serum and tissues by the time of 15 
skin incision with re-dosing to maintain therapeutic level of the drug in both serum and 16 
tissues throughout the operation and until a few hours after wound closure.[25] AMP does 17 
not pertain to prevention of SSI caused by post-operative contamination.[24] The fear of SSI 18 
and its attendant complications prompts many surgeons to continue antibiotics in the post-19 
operative period ranging for 24-48 hours[20,23] and often until drain removal. There is 20 
growing evidence in spine literature that this practice is unwarranted. AMP plays a vital role 21 
for preventing infection but indiscriminate and prolonged use of these drugs may expose 22 
patients to adverse drug reactions and encourage the emergence of resistant 23 
bacteria.[22,26,27] Hence an antimicrobial prophylaxis protocol which is safe, efficacious, 24 
requires the least number of doses to be administered and cost-effective is ideal. 25 
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The ‘Center for Disease Control (CDC) guideline for the prevention of SSI’[25] has 1 
made recommendations regarding the possible choice of prophylaxis antibiotics, i.e. an 2 
antimicrobial that is safe, inexpensive and bactericidal with an in-vivo spectrum that covers 3 
the most probable intra-operative contaminants. It also recommends the timing of infusion of 4 
the first dose and drug duration to establish and maintain therapeutic serum and tissue levels 5 
throughout surgery. There is however a paucity of literature regarding the application of this 6 
guideline in spine surgery[20,26,28] and none with regards to scoliosis surgery.  7 
The main aim of study is to document the efficacy of our present AMP protocol in 8 
preventing SSI and to compare it to our previous protocol of continued post-operative 9 
antimicrobial drug administration until drain removal for AIS surgery. Additional aims 10 
include evaluation of whether cephazolin (first-generation cephalosporin) is safe and 11 
efficacious in preventing SSI and identifying its risk factors. 12 
 13 
METHODS 14 
This was a comparative analysis of two consecutive series of patients (1993-2004, 15 
2005-2011) with AIS who had undergone posterior spinal fusion. Ethics approval was 16 
obtained from a local institutional review board. Patient characteristics included age, sex, and 17 
body mass index (BMI). Pre-operative risk factors for SSI including history of smoking, pre-18 
existing medical illness especially poor glycemic control, recent infection or persisting focus 19 
of infection and nutritional status in terms of total protein, albumin and globulin levels were 20 
recorded. Intra-operative and post-operative risk factors including estimated intra-operative 21 
blood loss, duration of surgery, number of vertebral levels fused and anchor points, post-22 
operative drain collection and its duration were recorded. The generic name and number of 23 
doses of the antimicrobial administered was noted. For patients receiving AMP according to 24 
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the CDC criteria, two additional doses were received postoperatively. For patients who 1 
received antimicrobials until drain removal, the number of days the drug was administered 2 
was recorded. For these patients, three doses of cephazolin were given per postoperative day 3 
(dosing every 8 hours). Serious adverse events including drug toxicity, allergic reaction or 4 
anaphylactic shock and antimicrobial associated colitis were recorded. 5 
A superficial infection was diagnosed with clinical signs of infection involving the 6 
skin, subcutaneous tissue, or muscle located above the fascial layer and accompanied by 7 
purulent drainage above the fascial layer and positive wound culture.[26] A deep infection 8 
was diagnosed when infection was found to involve tissue below the fascia. For each patient 9 
with SSI, the organism isolated, its antimicrobial sensitivity and subsequent management was 10 
recorded. Wound healing aberrations including delay in wound healing, wound dehiscence, 11 
hematoma or prolonged culture negative serous discharge, stitch abscess in the spine as well 12 
as in the iliac crest wound were noted. The post-operative follow-up notes were scrutinized 13 
for any late wound healing complications including infection after the skin healed and 14 
imaging confirmed pseudarthrosis.  15 
In our institution, patients were admitted the day prior to surgery and were screened 16 
for any active infective focus. In the presence of an active infection, surgery was postponed 17 
until the infection was eradicated. Necessary interventions were undertaken to optimize the 18 
patient’s preoperative general health status. All patients bathed the night prior to surgery, no 19 
shaving was performed and skin preparation was standardized with providone-iodine scrub. 20 
A standardized surgical procedure of autogenous bone grafting, implant insertion, deformity 21 
correction and fusion was performed in a laminar airflow theatre. Three independent spine 22 
specialists were involved in all the operations. All patients received autogenous blood 23 
transfusion (stored 1 month prior to operation). No cell saver was used. Autogenous bone 24 
graft used for fusion was harvested from the posterior iliac crest immediately prior to the 25 
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main spinal incision. No allograft bone or bone substitutes were used in any of the cases. The 1 
surgical sites were irrigated with normal saline after completion of surgical dissection, 2 
insertion of all anchors, after rod insertion and prior to wound closure. Standardized closure 3 
was performed with watertight closure of fascia and subcutaneous with continuous vicryl 4 
sutures, and buried subcuticular monocryl sutures. Single suction drain was routinely placed 5 
in the spinal wound and removed when the collection was <50 ml over a 24-hour period. No 6 
drains were placed in the iliac crest wound. No topical antibiotics were used. All preparation 7 
and surgical protocols were standardized between the three surgeons. 8 
Cephazolin, a first-generation cephalosporin, administered at a dose of 20-30mg/kg 9 
body weight was used as AMP. It was administered 30 minutes before skin incision and an 10 
additional dose administered intra-operatively every 4 hours to maintain therapeutic levels 11 
throughout surgery. Prior to 2005, antimicrobials were continued in the post-operative period 12 
until drain removal; however since then antimicrobials were only administered pre-incision 13 
with re-dosing intra-operatively when the procedure duration exceeds 4 hours. This practice 14 
was changed in 2005 following the advice of the infection control unit at our institution. 15 
Statistical analysis was performed using SPSS version 19. Analysis of variance 16 
(ANOVA) test was used to evaluate for differences in the pre-, intra- and post-operative 17 
variables between the two groups. Pearson’s chi-square test and Mann-Whitney tests were 18 
used for outcome analysis. Fisher’s Exact Test was employed when data points were less than 19 
or equal to 5. A p-value of <0.05 was considered significant. 20 
 21 
RESULTS 22 
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226 patients with average 43 months follow-up (range: 18-104 months) were included 1 
in the study, of which 155 (68.6%) patients (group A) received 2 doses of postoperative AMP 2 
and 71 (31.4%) patients (group B) received antimicrobials until drain removal (range: 3-5 3 
days). No significant differences were observed between the two groups (Table 1) with 4 
respect to mean age, sex, BMI, smoking, pre-operative hemoglobin, nutritional status (total 5 
protein and albumin), scoliosis curve type, mean number of levels fused per patient, intra-6 
operative transfusion, post-operative transfusion and duration of drain left in-situ. A 7 
significant difference was observed between the groups in terms of pre-operative globulin 8 
levels, type of instrumentation system, mean number of anchor points per patient, intra-9 
operative and post-operative blood loss between the groups. Although there was 10 
approximately 150ml more blood loss intra-operatively for group A, interestingly group B 11 
had more intraoperative and postoperative transfusions. Patients in group A had lower pre-12 
operative globulin levels and more anchor points per patient as compared to group B. The 13 
globulin levels however were in the normal range in both groups and hence this finding might 14 
not be clinically significant. Group B had fewer patients with all pedicle screw constructs as 15 
most of these patients were operated prior to popularization of all pedicle screw constructs 16 
(Table 2). 14 of 71 patients in Group B had a deep spine wound drain whilst all group A 17 
patients had a subcutaneous plane drain (due to a change in policy in drain usage) and this 18 
accounted for the difference in total drain output.  Too few patients in Group B had deep 19 
spine wound drains to find any statistical significant differences in SSI. No statistical 20 
differences in all patient parameters and outcomes were found between the 3 operating 21 
surgeons. 22 
For pre-existing medical problems, 14 patients had allergic rhinitis and or asthma, 2 23 
had atopy, 3 had G6PD deficiency, 3 patients had thalassemia trait and 2 with thalassemia 24 
minor, 5 patients had cardiac valve anomalies, 2 patients were obese and 1 had recovered 25 
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from leukemia. No patients had anemia or any active focus of infection. No patients had 1 
diabetes or abnormal blood glucose prior to surgery. 2 
The overall rate of SSI was 1.7% for the spine wound and 1.3% for the iliac crest 3 
wound. For the spine wound, 3 of 155 (1.9%) patients in group A had SSI (1 superficial and 2 4 
deep), while there was only 1 deep SSI (1.4%) in group B (p=1.0). For the iliac crest, two 5 
(1.3%) patients in group A, and one (1.4%) patient in group B had a superficial SSI (p=1.0). 6 
The organisms cultured and the management of the infected patients was detailed in table 3. 7 
All the deep infections were managed with a single debridement and antibiotics given 8 
according to culture sensitivity reports and none required implant removal. Duration of use 9 
depended on clinical response and microbiologist consultation. The superficial infections 10 
were managed with appropriate antibiotics only. There were no late infections seen. Nine of 11 
155 (5.8%) patients in group A and seven of 71 (9.8%) patients in group B had spine wound 12 
healing aberrations, but the difference was not significant (p=0.489). One of 155 (0.6%) 13 
patients in group A and four of 71 (5.6%) patients in group B had iliac crest wound healing 14 
aberrations, but the difference was also insignificant (p=0.059). None of these wound healing 15 
aberrations required further treatment besides observation. No adverse drug reactions or side 16 
effects attributable to cephazolin were observed.  17 
 18 
DISCUSSION 19 
This is the first study to compare the outcomes of two different AMP protocols. The 20 
overall rate of SSI in this study is 1.7% which is within the range of 0.71% to 6.9% as 21 
reported in literature.[10-15] In group A, the rate of spine wound SSI was 1.9%, while in 22 
group B, the rate was 1.4%. Statistically speaking, there were no significant differences in the 23 
prevalence of spine and iliac crest wound SSI. This implies that a short duration of AMP is 24 
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equally effective in reducing the rate of SSI as compared to post-operative continuation of 1 
AMP until drain removal. This also implies that cephazolin is an effective prophylactic 2 
antimicrobial agent. Furthermore, no adverse drug events are observed which demonstrates 3 
its safety.  4 
The particularly low infection rate in this study can be contributed to the type of 5 
patients operated on. All the AIS patients in this study are healthy teenagers who generally do 6 
not have high risk for infections to begin with. Poor glycemic control or diabetes mellitus has 7 
been shown to increase the risk of SSI.[29] As expected, this is not a risk factor found in our 8 
patients. 9 
Late infection after the surgical treatment of AIS is a concern. Its incidence ranges 10 
from 1.4% to 6.9%[13,30] and usually occurs at an average of 2 years after surgery. In our 11 
series, 201 patients were followed up for a minimum period of 24 months and no cases of late 12 
infection were found in either group. Our data suggests that a shorter duration of AMP does 13 
not predispose to an increased rate of late infection.  14 
A secondary outcome was to compare the prevalence of wound healing aberrations 15 
even though they did not affect the overall clinical outcome. This was done to ensure that a 16 
change in antibiotic schedule did not lead to any difference in wound healing. Interestingly, 17 
despite a longer duration of antibiotic use in group B patients, a larger percentage of patients 18 
had spine and iliac crest wound aberrations. Although this result was still statistically 19 
insignificant, it suggested that a shorter antibiotic regimen did not negatively affect wound 20 
healing. It should be noted that these wound healing complications did not result in delayed 21 
suture removal or prolonged hospital stay. 22 
The results of our study provide further evidence that short duration AMP is adequate 23 
even in extensive surgical procedures such as scoliosis correction that involves massive soft 24 
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tissue dissection, bone decortication and a large amount of instrumentation. None of the 1 
organisms isolated from group A patients were drug resistant, whereas 1 of 3 (33%) 2 
organisms isolated from group B patients (prolonged antibiotics) was methicillin-resistant 3 
Staphylococcus Aureus (MRSA). The prevalence of antibiotic resistant organism in our study 4 
is too low to comment on whether prolonged antibiotic use may lead to development of 5 
antibiotic resistance. However the evidence from our study and literature[17,22,26,31] leads 6 
us to believe that short duration AMP is effective and that prolonged drug administration 7 
post-operatively should be avoided to reduce the emergence of drug resistant organisms. 8 
Kanayama et al.[26] reported in their study that 83.3% of organisms isolated from patients 9 
with SSI in the multiple-dose group were resistant strains of bacteria, whereas none in the 10 
single-dose group were resistant. Unlike these studies, we do not see an increase in culture of 11 
resistant bacteria. 12 
The choice of prophylactic antimicrobial drug is an important factor in preventing 13 
SSI.[27,32] The ideal antibiotic should be safe, inexpensive, and bactericidal with an in-vivo 14 
spectrum that covers the most probable intra-operative contaminants. For orthopedic surgery, 15 
microorganisms classically recovered from wound infections in patients with no pre-existing 16 
focus of infection include Staphylococcus aureus, S. epidermidis, S. lugdunensis and 17 
Propionibaterium acnes.[15,22,27,33-36] Because of the frequency of isolation of these 18 
organisms, β-lactams such as cephalosporins and penicillins are most often selected for AMP. 19 
Cephalosporins have been shown in studies to be effective against many gram-positive and 20 
gram-negative microorganisms.[37] They also share the features of demonstrated safety, 21 
acceptable pharmacokinetics, and a reasonable cost per dose.[21] In particular, cephazolin is 22 
widely used and generally viewed as the first choice antimicrobial drug for clean operations. 23 
Authors of trials in which cephazolin was compared with second- and third-generation 24 
cephalosporins have failed to show any difference in efficacy.[26,38,39] The results of our 25 
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study combined with Rubinstein et al.[17], Takahashi et al.[20] and Kanayama et al.[26] 1 
provide evidence for the use of cephazolin as the first-line prophylactic antimicrobial agent 2 
for spinal surgery.  3 
The current study has the drawbacks of having a small sample size. An adequately 4 
powered prospective randomized clinical trial would be ideal to verify our findings especially 5 
considering this is a study on AMP. However considering the low rate of infection in 6 
scoliosis surgeries (approximately 2-3%) as pointed out by Dimick et al.[32], for a baseline 7 
infection rate of 2% it is necessary to enroll 2518 patients in each treatment group to detect a 8 
difference in SSI rates. Clearly, the magnitude of this number indicates that a multi-center 9 
clinical trial is required as we do not have over 5000 cases in our cohort to address this 10 
issue.[40] This is not only necessary for scoliosis patients but for all spine disorders as the 11 
current North American Spine Society guidelines provides only fair recommendations for 12 
antibiotic prophylaxis in spine surgery.[41] It should be cautioned that the external validity of 13 
the study may be limited for settings with increased resistance of S. epidermidis to β-lactam 14 
antibiotics, or hyper-endemic occurrence of MRSA. Another limitation is that the two groups 15 
include patients from two separate time periods and thus not as strong of a comparison as in a 16 
prospectively matched cohort. There are inherent differences in instrumentation (modern 17 
pedicle screw based and earlier hook based) and drain use (earlier deep placement beneath 18 
the thoracolumbar fascia and modern superficial placement). This may have an effect on the 19 
post-operative wound behaviour but interestingly there is no significant increase in operative 20 
time or postoperative increase in drain output for hook instrumentation nor deep drains. 21 
Although all three surgeons are experienced, the lack of differences in duration of surgery 22 
may reflect the difficulties of engaging hook anchors to rods in earlier patients. 23 
This is the first and largest study on AMP protocol in scoliosis surgery. Despite the 24 
reported limitations, results suggest that short duration AMP with cephazolin is safe, effective 25 
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and cost-effective in scoliosis surgery. The rates of infection are comparable to that reported 1 
in literature and there is no increased predisposition to late infection. Reduced number of 2 
doses of antimicrobials may reduce health care cost. Reduced adverse effects, negating need 3 
for intravenous access, reduced workload for the nursing staff and possibly prevention of 4 
antibiotic resistance are other potential advantages. This study is a platform for future 5 
prospective multicenter-randomized-controlled-trials to further establish this protocol for 6 
scoliosis surgery. 7 
 8 
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Table 1: Comparison of pre-operative, Intra-operative and post-operative variables 
between the two groups 
Variable  Group A (n=155); 
Mean (SD; range) 
Group B (n=71) 
Mean (SD; range) 
P-value 
Age (years) 15.03 (SD 2.642; 10-
27) 
15.11 (SD 2.72; 
11-25) 
0.833 
Sex (Female/Male) 132/23 60/11 0.899 
Body mass index 
(BMI) 
18.3 (SD 2.5; 13.52-
27.28) 
18.73 (SD 3.52; 
11.29-31.49) 
0.297 
Smoking (patients)  3 2 0.677 
Pre-operative 
Haemoglobin (g/dL) 
13.13 (SD 1.46; 9.8-
12.9) 
11.76 (SD 1.65; 
9.3-16.4) 
0.228 
Pre-operative total 
protein (g/L) 
75.15 (SD 6.54; 42-
89) 
75.52 (SD 6.70; 
47-87) 
0.699 
Pre-operative albumin 
(g/L) 
44.33 (SD 4.66; 17-
52) 
43.01 (SD 5.41; 
22-55) 
0.063 
Pre-operative globulin 
(g/L) 
30.80 (SD 3.78; 22-
41) 
32.55 (SD 3.17; 
25-40) 
<0.001  
Scoliosis curve type 
(MT/DM/DT/TM/TL) 
108/25/19/0/3 42/18/8/2/1 0.277 
Mean number of levels 
fused per patient 
9.26 (SD 2.06; 6-13) 9.8 (SD 2.23; 6-15) 0.770 
Surgical duration 
(minutes) 
283.91 (SD 64.85; 
188-480) 
277.94 (SD 70.7; 
192-430) 
0.533 
Mean number of 
anchor points per 
patient 
10.9 (SD 2.89; 6-21) 9.28 (SD 2.12;7-
17) 
<0.001 
Intra-operative blood 
loss (ml) 
796.29 (SD 391.83; 
250-2200) 
638.56 (SD 406.33; 
150-1850) 
0.006 
Intra-operative 
transfusion (ml) 
Blood: 402.94 (SD 
270.361; 0-1400) 
FFP: 248.01 (SD 
210.30; 0-785) 
Blood: 442.96 (SD 
322.68; 0-1445) 
FFP: 402.07 (SD 
301.15; 0-1000) 
0.150 
Post-operative 
transfusion (ml) 
Blood: 191.25 (SD 
198.80; 0-785) 
FFP: 23.32 (SD 
76.88; 0-570) 
Blood: 267.68 (SD 
292.43; 0-1250) 
FFP: 12.48 (SD 
75.47; 0-536) 
0.241 
Post-operative drain 
(spine) (ml) 
Total drain: 228.01 
(SD 231.78; 5-1510) 
Total drain: 473.01 
(SD 365.98; 5-
1740) 
0.01 
Post-operative duration 
of drain in-situ (days) 
 
3.1 (SD 0.65; 2-6) 
 
3.2 (SD 0.72 ; 2-7) 0.356 
 
Group A: Two doses of postoperative antimicrobials; Group B: Antimicrobials till drain removal 
*MT- Main thoracic, DM-double major, DT- double thoracic, TM- triple major, TL-
thoracolumbar, SD-standard deviation, FFP- fresh frozen plasma  
